Bayer India

CORONA Remedies deepens footprint in women's healthcare and cardiology with Bayer India portfolio acquisition, entering anti-platelet and hormone therapy segments

Diabetes is an epidemic in India, with nearly 100 million Indians suffering from it. Diabetes has also been identified as the leading cause of chronic kidney disease in India

As part of the collaboration, Krishi Vigyan Kendras will strengthen outreach to a wider farmers' base by leveraging technological know-how

Brand named Kerendia (finerenone) will cost Rs 97.5 per day as treatment cost in India

In late 2016, Monsanto withdrew an application seeking approval from New Delhi for the GM variety Bollgard II Roundup Ready Flex (RRF)

Narain, 58, might be a chartered accountant by qualification but farm business is where his heart lies

It will also benefit grape growers to maintain the health and freshness of grapes for a longer time by protecting against latent diseases, Bayer said